Tianjin Pharma DRT (SH600329)
Group Profile
Heritage of Ingenuity
Group News
Health Self-Check
Health Guide
中文
中文
English
search
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us
Tianjin Pharma DRT (SH600329)
35.17
+0.35 +1.01%
中文
English
Home Page
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Online Mall
Back
Home Page
Media Coverage
Content
证券时报网关注达仁堂：以行业高度、文化深度、社会温度 铸就百年老字号高质量发展新标杆
2026 / 04 / 08
稿件来源：证券时报APP
了解更多产品信息
欢迎点击进入
达仁堂官方小程序
往期回顾
胸痛中心大会重磅举行 多方共绘胸痛救治新蓝图
守护心健康！达仁堂三大实践路径助力胸痛体系建设
【“天津卫药”文化故事】散风活血膏：弃武从医者创风湿疼痛治疗奇方
节气养生 | 清明时节 疏肝气、健脾胃、祛湿浊
心血管专家教您听懂心脏“求救信号”
Previous：
人民日报专题报道｜中国游带火中国购 达仁堂国风好物实力出圈
Next：
达仁堂邀您关注大医说｜春日过敏季内外调养护肌肤
We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Home Page
>
Health Guide
>
Media Coverage
>
Content
